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Periodontal ligament mesenchymal stem cells (PDLMSCs) are an important alternative source of adult stem cells and may be applied for periodontal tissue regeneration, 
neuroregenerative medicine, and heart valve tissue engineering. However, little is known 
about the impact of bacterial toxins on the biological properties of PDLSMSCs, including 
self-renewal, differentiation, and synthesis of extracellular matrix. Objective: This study 
investigated whether proliferation, expression of pro-inflammatory cytokines, and 
osteogenic differentiation of CD105-enriched PDL progenitor cell populations (PDL-CD105+ 
cells) would be affected by exposure to bacterial lipopolysaccharide from Escherichia coli 
(EcLPS). Material and Methods: Toll-like receptor 4 (TLR4) expression was assessed in 
PDL-CD105+ cells by the immunostaining technique and confirmed using Western blotting 
assay. Afterwards, these cells were exposed to EcLPS, and the following assays were 
carried out: (i) cell viability using MTS; (ii) expression of the interleukin-1 beta (IL-1β), 
interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF-α) genes; 
(iii) osteoblast differentiation assessed by mineralization in vitro, and by mRNA levels of run-
related transcription factor-2 (RUNX2), alkaline phosphatase (ALP) and osteocalcin (OCN) 
determined by quantitative PCR. Results: PDL-CD105+ cells were identified as positive for 
TLR4. EcLPS did not affect cell viability, but induced a significant increase of transcripts for 
IL-6 and IL-8. Under osteogenic condition, PDL-CD105+ cells exposed to EcLPS presented 
an increase of mineralized matrix deposition and higher RUNX2 and ALP mRNA levels when 
compared to the control group. Conclusions: These results provide evidence that CD105-
enriched PDL progenitor cells are able to adapt to continuous Escherichia coli endotoxin 
challenge, leading to an upregulation of osteogenic activities.
Keywords: Cell differentiation. Bacterial antigens. Periodontal ligament. Stem cells. 
Osteogenesis.
INTRODUCTION
The great differentiation capacity of mesenchymal 
stem cells (MSCs), the possibility of grafting, and 
its expansion in culture led to an increased interest 
in the clinical use of these cells through directed 
administration on specific sites in many pathological 
situations. In this sense, regenerative therapy 
based on stem cells has gained attention since the 
isolation of mesenchymal stem cells from various 
tissues.
The search for similar cells to mesenchymal stem 
cells in specific tissues has led to the discovery of a 
variety of stem cells in almost all organs and tissues 
of the body in recent decades20. Dental tissue is a 
potent reservoir of postnatal stem/progenitor cells 
isolated from dental pulp4, periodontal ligament 
from permanent21 and deciduous teeth22, apical 
papilla24, or dental follicles17. These postnatal 
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populations cells have been characterized by 
the expression of specific surface markers to 
mesenchymal stem cells (CD105, CD166, CD73 e 
STRO1)21,22, and have stem cells-like properties, 
including the capacity for self-renewal and 
multilineage differentiation potential6. Periodontal 
ligament mesenchymal stem cells (PDLSCs) are 
an important alternative source of adult stem 
cells and may be applied in periodontal tissue 
regeneration21,25, neuroregenerative medicine3, 
and heart valve tissue engineering14. Although 
PDLSCs can be routinely isolated and cultivated 
from periodontal ligament, many issues have to 
be approached before these cells can be used for 
therapies, such as their growth and differentiation 
in the presence of bacterial toxins, which may be 
present in many clinical situations.
Lipopolysaccharide (LPS) is an endotoxin present 
in Gram-negative bacteria such as Escherichia coli. 
This endotoxin, when in contact with cells of the 
host immune system, as well as gingival fibroblasts, 
induces an immune-inflammatory response 
characterized by the release of pro-inflammatory 
cytokines, which are mediated by Toll-like receptors 
(TLR2 e TLR4)9. The feasibility of using PDLSCs in 
regenerative procedures by virtue of their capacity 
to differentiate into multiple cell lines depends on 
whether the growth and osteogenic differentiation 
of PDLSCs are affected by bacterial stimuli. Some 
studies suggest that periodontal ligament cells may 
alter their phenotype in response to inflammation 
promoted by bacterial lipopolysaccharide23,27. 
However, little is known about the interactions 
between bacteria and MSCs. Recently, it was 
observed16 that an in vitro change in osteogenic 
differentiation pattern occurs when mesenchymal 
stem cells isolated from the bone marrow of healthy 
individuals were exposed to the Escherichia coli LPS.
Thus, this study investigated the effects of 
lipopolysaccharides from Escherichia coli (EcLPS) 
on cell viability, expression of pro-inflammatory 
cytokines, and osteogenic differentiation potential 
of CD105-enriched PDL progenitor cell populations.
MATERIAL AND METHODS
Cell culture
This study was approved by the Institutional 
Review Board (#022/2011). Five populations of 
mesenchymal progenitor cells (STRO1+ CD105+ 
CD166+ CD34- CD45- cells) from periodontal dental 
ligament (PDL) of permanent teeth were obtained 
and characterized in a previous study22. Briefly, teeth 
extractions of completely erupted third molars of 
five subjects (aged 19 to 22 years) were performed 
at the Dental Clinic of the School of Dentistry, State 
University of Campinas, Piracicaba, São Paulo, 
Brazil. Teeth were placed in biopsy media composed 
of Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 250 
mg/ml gentamicin sulfate, 5 m/ml amphotericin 
B, and 1% penicillin/streptomycin (Gibco BRL, Life 
Technologies, Carlsbad, CA, USA), and transferred 
to the laboratory facilities. The PDL tissues from 
permanent teeth were gently scraped from the 
mid-portion of the root surface and enzymatically 
digested in a solution of 3 mg/ml collagenase type 
II (Gibco BRL) and 4 mg/ml dispase (Gibco BRL) 
for 1 hour at 37°C. Heterogeneous single-cell 
suspensions were obtained by passing the cells 
through a 70-mm cell strainer (Falcon, BD Labware, 
Franklin Lakes, NJ, USA). Samples were expanded 
in 25 cm2 culture flasks (Falcon) at 37°C, 5% CO2 in 
DMEM supplemented with 10% fetal bovine serum, 
1% L glutamine and 1% penicillin/streptomycin 
(Gibco BRL) (standard media). CD105+ enriched cell 
subsets from PDL (PDL-CD105+ cells) were isolated 
by magnetic cell sorting, and characterized by flow 
cytometry, and immunostaining. Flow cytometric 
analysis demonstrated a higher proportion of 
CD105+ cells co-expressing CD166 surface 
antigen, whereas immunostaining demonstrated 
expression of STRO-1. These cell populations 
showed multipotential capabilities to differentiate in 
vitro into an osteoblast phenotype and adipocyte-
like cells22. All five PDL-CD105+ cell populations were 
cultured in Dulbecco’s modified Eagle’s minimal 
essential medium (DMEM) supplemented with 
10% fetal bovine serum, 1% L glutamine and 2% 
penicillin/streptomycin (standard media) (Gibco 
BRL), frozen with Recovery™ Cell Culture Freezing 
Medium (Gibco BRL) and kept in liquid nitrogen for 
subsequent experiments.
Preparation of LPS solution from Escherichia 
coli
Bacterial LPS were suspended in 1 mL of sterile 
and endotoxin-free water as a stock solution 
(concentration 1 mg/mL) of Escherichia coli (Sigma-
Aldrich, St Louis, MO, USA), and stored at -20°C. At 
the time of each experiment, the concentrations of 
100 ng/mL, 1 µg/mL e 10 µg/mL10 were obtained by 
diluting each LPS in DMEM from the stock solution.
Immunostaining for TLR4
To evaluate the expression pattern of Toll-like 
receptor 4 (TLR4), PDL-CD105+ cell populations 
were seeded at 4×104 cells/well on glass coverslips 
(13 mm, Knittel® GmbH, Braunschweig, Germany), 
placed in 24-well plates (Falcon), and cultured for 
24 hours in standard media. Afterwards, cells were 
fixed in 4% paraformaldehyde for 10 minutes, 
blocked with 3% bovine serum albumin (BSA, 
Sigma-Aldrich) for 30 minutes, and incubated with 
a mouse antihuman TLR4 antibody (1:50; Abcam, 
Cambridge, MA, UK) for 1 h. Subsequently, cells 
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were incubated with a secondary antibody Goat anti-
mouse IgG Alexa fluor 488 (1:1000) (Invitrogen, 
Carlsbad, CA, USA) for 1 hour. In order to identify 
nuclei, the samples were counterstained with TO-
PRO®-3 iodide 642/661 (1:2000) (Invitrogen) for 15 
minutes. As a negative control, cells were incubated 
only with the secondary antibody. Samples were 
then analyzed by confocal laser scanning microscopy 
(Leica TCS SP5AOBS, Mannheim, Germany).
Western Blot analysis for TLR4
Total cellular protein was extracted from cultured 
PDL-CD105+ cell populations using the RIPA buffer 
(Thermo Scientific, Rockford, IL, USA) supplemented 
with protease inhibitor cocktail (Sigma, P2714), 
following the manufacturer’s specifications. Protein 
concentration was measured by the Bradford 
method (Bio-Rad Laboratories, Benicia, CA, USA) 
with bovine serum albumin (BSA) as a standard, and 
was measured spectrophotometrically at 595 nm. 
Equal amounts of protein per sample were separated 
by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS–PAGE) 10% and transferred 
to a nitrocellulose membrane (Amersham™ Hybond 
ECL, Amersham BioSciences™, GE Healthcare, Little 
Chalfont, Buckinghamshire, UK). The membranes 
were blocked with 3% BSA in TBS for 1h at room 
temperature, incubated overnight with a 1:1000 
dilution of primary antibody mouse anti-human 
TLR4 (Abcam), and then incubated with peroxidase-
conjugated secondary antibodies (Anti-mouse 
1:2500) (Santa Cruz Biotechnology, Dallas, TX, 
USA) for 2 h. The membrane was developed using 
an ECL reagent (SuperSignal West Femto Substrate, 
Thermo Scientific) and the signals were detected 
using radiographic films (Kodak, Rochester, NY, 
USA).
Cell viability assay
The MTS assay was used to determine cell viability 
of PDL-CD105+ cells. Single-cell suspensions 
(1.5×104 cells/well) were seeded on 96-well plates 
with standard media for 24 h for cell attachment 
and spreading. Subsequently, media was changed 
to standard medium containing 0, 100 ng/mL, 1 µg/
mL or 10 µg/mL concentrations of EcLPS, and cells 
were cultured for 10 days. At time points of 1, 3, 7, 
and 10 days, MTS reagent (Promega Co., Madison, 
WI, USA) was added, and cells were incubated 
for 2 h at 37°C in a humidified CO2 incubator. 
The absorbance of the formed formazan dye was 
measured photometrically at 490 nm.
Cytokines gene expression 
Cells were seeded on a 60-mm dish (2×105 cells/
dish) with standard media for 24 h. Subsequently, 
media was changed to standard media supplemented 
with 0, 100 ng/mL, 1 µg/mL or 10 µg/mL of EcLPS. 
After 24 hours, total RNA was obtained using TRIzol® 
reagent (Invitrogen) to determine the expression 
of transcripts corresponding to interleukin-1 beta 
(IL-1β), interleukin 6 (IL-6), interleukin 8 (IL-8), 
and tumor necrosis factor alpha (TNF-α).
Osteogenic induction
PDL-CD105+ cells were seeded 2×105 in 60-
mm tissue culture dishes in standard media for 
gene expression analysis and in 24-well plates to 
assess the mineral nodule formation in vitro. After 
24 hours, standard medium was changed to an 
osteogenic-inducing medium (DMEM 10% FBS, 50 
µg/ml ascorbic acid, 10 mM β-glycerol-phosphate, 
10-8 M dexamethasone). To evaluate the effect of 
LPS on osteogenic differentiation, the differentiation 
medium was also supplemented with 1 µg/mL E. 
coli LPS. Total RNA was obtained using a reagent 
(TRIzol®, Invitrogen) at days 3, 7, and 14 for the 
determination of the expression of transcripts 
corresponding to ALP, OCN, and RUNX2. In parallel, 
in vitro mineral nodule formation was assessed at 
day 21 using the alizarin Red assay (Sigma-Aldrich). 
For that, after 21 days of differentiation, cells were 
fixed with 70% ethanol and stained with alizarin 
Red (Sigma-Aldrich) for calcium detection. For 
Gene     Foward Primer     Reverse Primer Amplicon
ALP 5’-cgggcaccatgaaggaaa-3’ 5’-ggccagaccaaagatagagtt-3’ 184
OCN 5’-agctcaatccggactgt-3’ 5’-ggaagaggaaagaagggtgc-3’ 150
RUNX2 5’-ccgtccatccactctaccac-3’ 5’-atgaaatgcttgggaactgc-3’ 139
IL-1β 5’-cttcttcgacacatgggataac-3’ 5’-tttgggatctacactctccagc-3’ 283
IL-6 5’-ctagagtacctccagaacagatttga-3’ 5’-tcagcaggctggcattt-3’ 154
IL-8 5’-gccaagagaatatccgaactttaat-3’ 5’-ctggctagcagactaggg-3’ 172
TNF-α 5’-tccacccatgtactcctcac-3’ 5’-cctcccagatagatgggctcata-3’ 155
GAPDH 5’-acatcatccctgcctctac-3’ 5’-ccaccttcttgatgtcatcatatttg-3’ 171
ALP, alkaline phosphatase; OCN, osteocalcin; RUNX-2, runt-related transcription factor 2; IL-1β, interleukin-1 beta; IL-6, 
interleukin 6; IL-8, interleukin 8; TNF-α, tumor necrosis factor alpha; GAPDH, glyceraldehyde-3-phosphate dehydrogenase
Figure 1-  Primers sequence used for amplification in real-time PCR
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quantitative measurement, alizarin was solved in a 
10% cetylpyridinium chloride monohydrate solution 
(PBS) for 15 min and samples were measured in a 
plate reader at 562 nm.
Gene expression analysis
Total RNA was DNase treated (Turbo DNA-
free, Ambion, Foster City, CA, USA), and single-
stranded complementary DNA (cDNA) was 
synthetized from 1 µg of total RNA using a kit (First 
Strand cDNA synthesis kit, Roche Diagnostics, 
Indianapolis, IN, USA) following the manufacturer’s 
recommendations. Primers sequences for ALP, 
OCN, RUNX2, IL-1β, IL-6, IL-8, TNF-α and glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) 
are shown in Figure 1. qRT-PCR was performed 
with the LightCycler 2.0 and software (Roche 
Diagnostics GmbH, Mannheim, Germany), using 
the FastStart DNA Master plus SYBR Green Kit 
(Roche Diagnostics). Water (no template) was 
used as a negative control for all experiments. 
Relative quantification of reaction products was 
accomplished using GAPDH as the reference gene.
Statistical analysis
All experiments were performed in triplicate 
and repeated on at least three separate occasions. 
Mean and standard deviation were obtained to 
establish statistical comparisons. Data comparison 
was performed using one-way analysis of variance 
test (α=0.05), and pairwise multiple-comparison 
test (Tukey test) was used to identify the difference 
among the groups. Additionally, non-parametric 
Kruskal-Wallis test (α=0.05) followed by the 
Student-Newman-Keuls was performed to assess 
the effect of LPS on cytokines gene expression 
(BioEstat 5.0, Belém, PA, Brazil).
RESULTS
PDL-CD105+ cells express LPS receptor
Immunofluorescence analysis revealed that 
PDL-CD105+ cells exhibited positive staining for 
TLR4, which is a specific molecule involved in E. 
coli LPS signaling pathways (Figures 2A and 2B).
This positivity for TLR4 was confirmed by the 
Western blotting analysis, showing that all five 
cell populations assessed expressed this receptor 
(Figure 2C).
E coli LPS induces PDL-CD105+ response
To verify whether PDL-CD105+ cells responded to 
E. coli LPS, a metabolic activity as an indicator for 
cell viability was first measured using MTS assay. All 
PDL-CD105+ populations from five donors were able 
to retain the capacity to form adherent colonies and 
fibroblast spindle-shape after exposure to E. coli 
LPS (data not presented). As shown in Figure 3A, 
LPS did not affect the proliferation of PDL-CD105+ 
cells during the 10-day period, even after incubation 
with a relatively high concentration of endotoxin (1 
µg and 10 µg/mL). In addition, MTS values showed 
a time-dependent increase of cell proliferation in all 
groups, with a higher number of cells after 3 and 7 
days in the culture (Figure 3A).
Next, a qRT-PCR was performed to assess gene 
expression changes on pro-inflammatory cytokines 
IL-1β, TNF-α, IL-6 and IL-8 in PDL-CD105+ cells. After 
24 h of toxin challenge, EcLPS at concentrations of 
100 ng and 1 µg/mL induced a significant increase 
of the transcripts for IL-6 and IL-8 compared to 
the control group (Figure 3B). Despite the fact 
that PDL-CD105+ cells only expressed IL-1β and 
TNF-α mRNA after LPS challenge, there were no 
Figure 2- Highly purified CD105+ subsets of periodontal ligament (PDL) cells express Toll-like receptor 4 (TLR4). (A) 
Positive immunofluorescence for the TLR4 with nuclear localization confirmed by TO-PRO®-3 staining. (B) Control are 
represented by PDL-CD105+ cells incubated only with secondary antibody. (C) Western blotting analysis confirmed TLR4 
in the five PDL-CD105+ cells
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significant differences between cell exposed versus 
non-exposed, probably due to the greater variability 
of IL-1β and TNF-α expression among the five 
populations (Figure 3B).
LPS challenge enhances osteogenic 
differentiation of PDL-CD105+ cells
Having demonstrated that EcLPS (100 ng 
and 1 µg/mL) induced a pro-inflammatory 
cytokines response in PDL-CD105+ cells, next it 
was investigated whether EcLPS could change 
the osteogenic properties of these cells. For this 
evaluation, cells were only exposed to EcLPS at 
concentration of 1 µg/mL, and mineral nodule 
deposits (Alizarin Red staining) and gene expression 
of osteogenic markers (RUNX2, ALP, and OCN) were 
assessed.
After three weeks of osteogenic induction, 
mineral nodule formation could be observed in 
osteogenic differentiated cells of the positive 
control, as demonstrated by the quantification 
of Alizarin Red crystals (Figure 4A). This mineral 
deposition was increased when cells were exposed 
to osteogenic medium and E. coli LPS (Figure 4A). 
No mineralized nodules were observed in cells 
cultured in the DMEM used as a control (Figure 
Figure 3- Effect of E. coli lipopolysaccharide (LPS) on the viability and pro-inflammatory cytokines expression. (A) PDL-
CD105+ cells were cultured in the presence of EcLPS at concentrations of 0, 100 ng, 1 µg and 10 μg/ml. Metabolic activity 
as an indicator for cell viability was measured with MTS assay at the following time points: 1, 3, 7 and 10 days. (B) Real-
time PCR showed an increase of mRNA levels of IL-6, IL-8, IL-1β and TNF-α, respectively, in PDL-CD105+ cells after 
24 hours of EcLPS exposure. Representative data of three independent experiments are shown. Statistical significance 
intergroup is indicated by * (p<0.05)
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4A). qRT-PCR analysis further demonstrated 
an increased expression of a key osteoblast 
transcription factor, RUNX2, and two osteoblast-
specific early/late differentiation transcripts (ALP 
and OCN, respectively) in osteogenically-induced 
cells compared to non-induced (Figure 4B). When 
cells were cultured in an osteogenic medium 
supplemented with E. coli LPS, higher levels of 
transcripts for RUNX2, ALP, and OCN were found 
on day 7 after osteogenic induction (Figure 4B), 
although there is no significant differences between 
cells induced and non-induced with bacterial toxin. 
However, taken together, these data suggest that 
LPS challenge enhances osteogenic differentiation 
of PDL-CD105+ cells.
DISCUSSION
This study investigated the effects of LPS from 
enterobacteria Escherichia coli on CD105-enriched 
PDL progenitor cell populations (PDL-CD105+ 
cells). The surface marker CD105 was chosen for 
sorting progenitor cells from PDL heterogeneous 
population, since it is the most frequently reported 
positive surface marker in MSCs22. In addition, the 
expression of CD105 is one of the minimal criteria to 
define human MSCs according to the Mesenchymal 
and Tissue Stem Cell Committee of the International 
Society for Cellular Therapy2. As part of cell 
characterization, the present study showed that 
TLR4 was expressed by CD105-enriched PDL 
progenitor cell populations. This finding is in 
accordance with previous studies which have also 
reported that TLR4 are expressed by mesenchymal 
stem cells such as bone marrow mesenchymal 
stem cells7,13 and periodontal ligament stem cells13. 
The family of the Toll-like receptors is involved in 
recognition of bacterial cell wall components15, and 
it has been described that E. coli LPS trigger an 
inflammatory environment by binding to TLR41,7,13.
To evaluate the influence of E. coli-derived 
LPS on cell proliferation, CD105-enriched PDL 
progenitor cell populations were initially cultured 
in the presence of different concentrations of this 
Figure 4- Osteoblast differentiation of PDL-CD105+ cells under EcLPS exposure. (A) Quantification of Alizarin Red staining 
showed that EcLPS at concentration of 1 μg/ml increased mineral nodule formation at 21 d. (B) PDL-CD105+ cells were 
cultured in osteogenic medium (OM) alone or in OM+EcLPS (1 μg/ml). Data are presented as fold increase relative to 
non-induced controls for quantitative real-time PCR analysis showing that EcLPS did not alter the expression pattern of 
mRNAs for RUNX2, ALP, and OCN. All genes tested were normalized to the corresponding housekeeping gene, GAPDH. 
Representative data of three independent experiments are presented. Bars in (A) represent mean±standard deviation (SD) 
where intergroup statistical differences analysis are indicated by different capital letters (p<0.05)
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bacterial toxin. The findings showed that cells 
remained viable and proliferative regardless of 
the LPS concentration. These data corroborate the 
findings of other studies, which assessed the effect 
of Escherichia coli endotoxins in pre-osteoblastic 
cells11, bone marrow mesenchymal stem cells14, 
adipose-derived stromal cells8, and dental follicle 
stem cells18.
Since LPS from E. coli did not change cell growth, 
it was determined whether this endotoxin had any 
effect on cellular inflammatory response. It was 
found that EcLPS induced a significant expression of 
IL-6 and IL-8 in PDL-CD105+ cells. In addition, this 
bacterial toxin was able to induce the expression of 
two pro-inflammatory cytokines, IL-1β and TNF-α. 
However, there were no significant differences 
between PDL-CD105+ cells exposed to EcLPS 
versus non-exposed, probably due to the greater 
variability of IL-1β and TNF-α expression among the 
five cell populations. Similar to our data, previous 
studies had already observed an inflammatory 
response of oral cells exposed to LPS from E. coli. 
The expression of IL-6 and IL-8 were induced in 
periodontal ligament cells26, while in dental follicle 
stem cells (DFCs) the gene for IL-1β could also be 
observed after exposure to EcLPS18.
Some evidences of the literature supports the 
notion that inflammatory environment mediated 
by lipopolysaccharides can inhibit osteoblast 
differentiation of human periodontal ligament 
stem cells12,13, mouse bone marrow mesenchymal 
stem cells7, and osteoblastic precursor cell line 
– MC3T3-E15. It has been suggested that LPS 
decreases the osteogenic potential of mesenchymal 
stem cells through TLR4 regulated nuclear factor 
(NF)-kB pathway7,13. Further, in osteoblastic 
precursor cells (MC3T3-E1), LPS seems to induce 
cell apoptosis and inhibit osteoblast differentiation 
via c-Jun N-terminal kinases (JNK) pathway5.
Our findings demonstrated that the inflammatory 
response induced by E. coli LPS did not affect the 
osteoblast differentiation of CD105-enriched PDL 
progenitor cell populations. Unlike the studies cited 
above5,7,12,13, EcLPS challenge increased mineralized 
nodules deposition through the osteogenic induction 
in PDL-CD105+ cells. Further, it is possible to 
suggest that EcLPS exposure induces an early 
osteoblast differentiation of PDL-CD105+ cells as 
demonstrated by increased expression of RUNX2 
and ALP transcripts at day 7 of osteogenic induction. 
In agreement with our data, the prolonged exposure 
to EcLPS upregulated ALP activity and calcium 
deposition in human bone marrow mesenchymal 
stem cells16, and could also promote an increase 
in osteogenic marker genes expression such as 
ALP, osteopontin and bone morphogenetic protein 
2 (BMP-2) in adipose-derived stromal cells8.
In the present study, prolonged endotoxin 
exposure was designed to mimic a situation in which 
mesenchymal stem cells interact continuously with 
bacterial toxins during an inflammatory chronic 
disease, and then to evaluate whether this bacterial 
challenge could affect the osteogenic properties of 
periodontal ligament progenitor cells. Our findings 
suggest that CD105-enriched periodontal ligament 
progenitor cell populations acquire an adaptive 
tolerance under continuous LPS exposure. Previous 
studies reported endotoxin tolerance in oral mucosa 
cells associated with chronic periodontitis19. Also, 
transcripts for TLR2 and TLR4 were significantly 
downregulated in the gingival tissue of patients 
with chronic periodontitis, suggesting that the oral 
mucosa develops endotoxin tolerance in chronic 
periodontitis19. Interestingly, we also observed a 
downregulation of TLR4 in PDL-CD105+ cells under 
osteogenic induction associated to E. coli LPS 
exposure (data not shown). 
However, further studies are required to 
elucidate the biological mechanism involved in the 
adaptive response by CD105-enriched periodontal 
ligament progenitor cells under continuous 
endotoxin exposure.
CONCLUSIONS
In conclusion, the results provide evidence that 
CD105-enriched PDL progenitor cells are able to 
adapt to continuous Escherichia coli endotoxin 
challenge, leading to an upregulation of osteogenic 
activities.
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